Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease.
Palm, Noah W; de Zoete, Marcel R; Cullen, Thomas W; Barry, Natasha A; Stefanowski, Jonathan; Hao, Liming; Degnan, Patrick H; Hu, Jianzhong; Peter, Inga; Zhang, Wei; Ruggiero, Elizabeth; Cho, Judy H; Goodman, Andrew L; Flavell, Richard A.
; 158(5): 1000-1010, 2014 Aug 28.
Artigo em Inglês | MEDLINE | ID: mdl-25171403
Disease-specific alterations in the enteric virome in inflammatory bowel disease.
Targeting immune cell circuits and trafficking in inflammatory bowel disease.
Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease.
Microbiota as Therapeutic Targets.
Inflammatory bowel disease as a model for translating the microbiome.
Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
Improvement of a 'Leaky' Intestinal Barrier.
C4B gene influences intestinal microbiota through complement activation in patients with paediatric-onset inflammatory bowel disease.
Fungal microbiota dysbiosis in IBD.
Mujer y enfermedad inflamatoria intestinal